0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$ ०.५१
०.००%
(०.००) 1D
अक्टोबर १६, १६:०८:१४ GMT+८ · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
HK$ ०.५१
High
HK$ ०.५२
Low
HK$ ०.५१
Mkt. cap
४.९० अरब
Avg. vol.
१६.६३ लाख
Volume
९.५६ लाख
52-wk high
HK$ १.०२
52-wk low
HK$ ०.५१
EPS
-HK$ ०.०१
Shares outstanding
९.६१ अरब
No. of employees
२ हजार
Open
HK$ ०.५१
High
HK$ ०.५२
Low
HK$ ०.५१
Mkt. cap
४.९० अरब
Avg. vol.
१६.६३ लाख
Volume
९.५६ लाख
52-wk high
HK$ १.०२
52-wk low
HK$ ०.५१
EPS
-HK$ ०.०१
Shares outstanding
९.६१ अरब
No. of employees
२ हजार
News stories
From web sources and news partners
Business Wire
·
३४ मिनेट पहिले
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
Simply Wall Street
·
५१ मिनेट पहिले
KLA (KLAC) Stock Is Caught In A Historic Chip Equipment Losing Streak
TradingView
·
५५ मिनेट पहिले
News by CNBC TV18 on TradingView, 2026-10-18 — cnbctv:f99f7968e094b:0
Bloomberg.com
·
१ घण्टा पहिले
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc